Trials / Completed
CompletedNCT03971981
Xylitol Chewing-gums: Concentration in Saliva and Antibacterial Effect
Xylitol Chewing-gums: Concentration in Saliva and Antibacterial Effect (In-vivo and In-vitro Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Università degli Studi di Sassari · Academic / Other
- Sex
- All
- Age
- 19 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
a double-blind cross-over in vivo study was performed to measure the salivary concentration of Xylitol released from the two chewing gums containing different amount of the polyol. The study had a cross-over design: the first half of the sample used the chewing-gum with Xylitol as the only sweeteners (64.5% of chewing-gum weight) and the other half use the chewing-gum with Xylitol among the sweeteners (22% of chewing-gum weight), after a 7-days wash-out period, the two sub-groups inverted the chewing gums. Subjects were instructed to consume the products as they normally would be consumed.
Detailed description
x
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 100% Xylitol Gum | Subjects were instructed to consume the gums as they normally would be consumed. |
| DIETARY_SUPPLEMENT | 22% Xylitol Gum | Subjects were instructed to consume the gums as they normally would be consumed. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2018-05-31
- Completion
- 2019-05-28
- First posted
- 2019-06-03
- Last updated
- 2019-06-03
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03971981. Inclusion in this directory is not an endorsement.